NR
NeuroSense Therapeutics Ltd.
NRSNW · NASDAQ
$0.04 +0.00% (+$0.00)
1M +14.80%
Market Cap $986.7K
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.05
25.0% upside
Current Price
$0.04
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NRSNW is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Valuation
-
N/A P/FCF N/A
P/E N/A
P/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
57 /100
Average Asset turnover 0.00x
ROIC 797.48%
ROA 1,082.20%
Debt
0 /100
High Int. coverage -652.06x
Current ratio 0.31x
Debt/Assets N/A
Stability
53 /100
Moderate Profitable years 0
Beta 1.60x
EPS volatility 7.33%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NRSNW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Alon Ben-Noon
Employees
16
Headquarters
Herzliya
Upcoming events
02 DEC
Earnings
Upcoming earnings report